ERBB3 and neoplasm: The ability of the PAbs generated by the Mv-HER3 candidate to recognize the murine ErbB3 receptor allowed us to evaluate the antitumor effect of this candidate in the 3LL-R3 tumor cell line and will also allow us to extend the evaluation of the antitumor effects to several mErbB3-positive mouse models.